Bill
S 3011
Bill S 3011 prohibits abortion and transgender procedures from health insurance exchanges, limiting access for individuals and impacting healthcare providers and insurers.
Bill S 3011, titled the Prohibiting Abortion & Transgender Procedures on the Exchanges Act, was introduced in the Senate on October 15, 2025. The primary intent of this legislation is to restrict access to abortion services and transgender-related medical procedures through health insurance exchanges.
The main purpose of S 3011 is to:
- Prohibit the inclusion of abortion services and transgender medical procedures in health insurance plans offered on federal and state health insurance exchanges.
- Restrict funding and coverage for these services, aiming to limit their availability to individuals seeking such care.
While the bill is currently in its introductory phase, the following key provisions can be anticipated based on its title and intent:
- Exclusion of Services: The bill would explicitly exclude abortion and transgender medical procedures from being covered by health insurance plans available on the exchanges.
- Impact on Insurance Providers: Insurance companies would be required to adjust their offerings to comply with the new restrictions, potentially leading to a reduction in available healthcare options for individuals seeking these services.
The bill would primarily affect:
- Individuals Seeking Care: Those who rely on health insurance exchanges for access to abortion services and transgender-related healthcare would find these options unavailable.
- Healthcare Providers: Medical professionals and organizations that provide abortion and transgender healthcare services may face reduced patient access and financial implications due to the lack of insurance coverage.
- Insurance Companies: Providers would need to revise their plans and coverage options to align with the new legal requirements.
Bill S 3011 seeks to impose significant restrictions on abortion and transgender healthcare services within health insurance exchanges. As it progresses through the legislative process, its implications for individuals, healthcare providers, and insurance companies will be closely monitored. Further details and potential amendments may emerge as the bill undergoes review and discussion in committee.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
